Results 31 to 40 of about 222,704 (323)
Incidence and drug treatment of emotional distress after cancer diagnosis : a matched primary care case-control study [PDF]
, 2012 Notes This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.Peer ...
A J Lee +33 more
core +1 more source
BMJ Mental Health, 2023 Background The association between antipsychotics and cardiovascular diseases (CVDs) remains significant yet unestablished, especially in Chinese populations.Objective To investigate the risk of CVDs associated with antipsychotics among Chinese ...
Peng Peng +7 more
doaj +1 more source
Challenges and pitfalls of antipsychotic prescribing in people with learning disability [PDF]
, 2017 No abstract ...
Alexander, Regi T. +7 more
core +1 more source
JAMA Network Open, 2019 Key Points Question Which atypical antipsychotic is most beneficial and safe for the treatment of behavioral and psychological symptoms of dementia? Findings In this network meta-analysis of 17 studies (5373 patients), no significant differences were ...
Ismaeel Yunusa +4 more
semanticscholar +1 more source
Therapeutics and Clinical Risk Management, 2017 Since the discovery of chlorpromazine (CPZ) in 1952, first-generation antipsychotics (FGAs) have revolutionized psychiatric care in terms of facilitating discharge from hospital and enabling large numbers of patients with severe mental illness (SMI) to ...
M. Solmi +11 more
semanticscholar +1 more source
Drug-induced liver injury in association with antipsychotics
European Psychiatry, 2022 Introduction Drug-induced liver injury is one of the leading causes for acute liver failure and drug withdrawal after marketing approval. One important risk factor is the extent of exposure of the hepatocytes to a substance, either by high doses or by ...
R. Zeiss, M. Gahr
doaj +1 more source
Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A meta-analysis of randomised controlled treatment trials [PDF]
, 2006 Small studies have shown positive effects from adding a variety of antipsychotic agents in patients with obsessive–compulsive disorder who are unresponsive to treatment with serotonin reuptake inhibitors. The evidence, however, is contradictory.
Carey, P +8 more
core +1 more source
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses
Therapeutic Advances in Psychopharmacology, 2018 Schizophrenia is the eighth leading cause of disability worldwide in people aged 15–44 years. Before antidopaminergic antipsychotics were introduced in the 1950s, no effective medications existed for the treatment of schizophrenia. This review summarizes
P. Haddad, C. Correll
semanticscholar +1 more source
Dosing strategies for switching from oral risperidone to paliperidone palmitate: Effects on clinical outcomes. [PDF]
, 2017 IntroductionThere are currently no guidelines for switching patients from oral risperidone to paliperidone palmitate (Invega Sustenna®). Furthermore, the paliperidone long-acting injectable (LAI) package insert does not recommend bridging with oral ...
Hsia, Stephanie L +4 more
core +2 more sources
Psychiatry and Clinical Psychopharmacology, 2021 Objective: Schizophrenia is a devastating disorder, starting in early adulthood and continuing with relapses and remissions. Prevalence of schizophrenia is 1% and the life expectancy of these patients is reduced.
Mehmet Akif Camkurt +6 more
doaj